Issue 4/2016
Content (8 Articles)
Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date
Vladimir Lerner, Peter J. A. McCaffery, Michael S. Ritsner
A Review of Pharmacologic Treatment for Compulsive Buying Disorder
Célia Soares, Natália Fernandes, Pedro Morgado
Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management
Jan Jaracz, Karolina Gattner, Krystyna Jaracz, Krystyna Górna
The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome
Alon Y. Avidan, Daniel Lee, Margaret Park, Mark J. Jaros, Gwendoline Shang, Richard Kim
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database
Chris Bushe, Esther Sobanski, David Coghill, Lovisa Berggren, Katrien De Bruyckere, Sami Leppämäki
Erratum to: Targeting CGRP: A New Era for Migraine Treatment
Stephanie Wrobel Goldberg, Stephen David Silberstein